Results 81 to 90 of about 12,800 (198)

Adipsic Hypernatremia Complicated by Hyperosmolar Hyperglycemic State and Extensive Venous Thromboembolism After Traumatic Brain Injury: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACTAdipsic hypernatremia is a rare disorder characterized by impaired thirst perception despite severe hyperosmolality, most commonly resulting from hypothalamic dysfunction. Hyperosmolar hyperglycemic state (HHS) may further aggravate dehydration and electrolyte imbalance, increasing the risk of neurologic injury, acute kidney injury (AKI), and ...
Mahshad Ghoddusi   +6 more
wiley   +1 more source

Melatonin Levels in 89 Individuals With Smith Magenis Syndrome

open access: yesAmerican Journal of Medical Genetics Part A, Volume 200, Issue 10, Page 2260-2272, October 2026.
ABSTRACT In patients with Smith–Magenis syndrome (SMS), an inverted circadian rhythm of melatonin (MT) contributes to the sleep disturbance. Standard treatment of sleep disturbance with MT often leads to extremely high daytime MT levels, resulting in even more sleep disorders. We therefore retrospectively evaluated the MT data of 89 SMS patients.
Wiebe Braam, Ann C. M. Smith
wiley   +1 more source

Side effects of desmopressin in patients with bleeding disorders

open access: yes, 2015
Desmopressin is frequently used in patients with bleeding disorders because of its prohaemostatic effects. In recent years desmopressin use increased due to reported high incidence of inhibitors in mild haemophilia after clotting factor infusion and the ...
Cnossen, M.H. (Marjon)   +14 more
core   +1 more source

Pilot study on the safety and efficacy of desmopressin for the treatment or prevention of bleeding in patients with hematologic malignancies

open access: yesHaematologica, 1997
BACKGROUND AND OBJECTIVES: Desmopressin is the treatment of choice for patients with von Willebrand's disease and mild hemophilia A. This compound is also useful in other congenital and acquired disorders of hemostasis, reducing the need for blood ...
G Castaman   +5 more
doaj  

Transdermal Delivery of Desmopressin Acetate from Water-in- Oil Nano/submicron Emulsion Systems [PDF]

open access: yesIranian Journal of Chemical Engineering, 2016
Desmopressin acetate is a potent synthetic peptide hormone. A more acceptable route of Desmopressin acetate is a potent synthetic peptide hormone. That is administered via parenteral, intranasal, and oral routes. A more acceptable route of administration
Arezou Soroushnia   +2 more
doaj  

Prolonged urinary drainage from nephrostomy tract after percutaneous nephrolithotomy can be treated with oral desmopressin

open access: yes, 2004
Desmopressin has been used in the treatment of nocturnal polyuria, diabetes insipitus and primary nocturnal enuresis. We present a patient who experienced prolonged urinary drainage after percutaneous nephrolithotomy but did not respond to insertion of a
Akbulut, Z   +3 more
core   +1 more source

Qualitative detection of desmopressin in plasma by liquid chromatography-tandem mass spectrometry [PDF]

open access: yes, 2012
This work describes a liquid chromatography-electrospray tandem mass spectrometry method for detection of desmopressin in human plasma in the low femtomolar range.
Goessaert, An-Sofie   +7 more
core   +1 more source

The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis

open access: yes, 2007
Purpose: Desmopressin is a well established and effective therapy for nocturnal enuresis. Water intoxication leading to hyponatremia is an infrequent but serious adverse event associated with desmopressin.
Leung, A. K. C.   +4 more
core   +2 more sources

Oral Desmopressin Lyophilisate Formulation (MELT): Efficacy and Safety in Children and Adults

open access: yes, 2018
Nocturnal enuresis (NE) is a common disorder in childhood and desmopressin is one of the most widely and well-tolerated medications for NE. The recent oral lyophilisate formulation of desmopressin (MELT) is effective in the treatment of NE in children ...
P. Ferrara   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy